Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3860
-0.0009 (-0.23%)
At close: Mar 13, 2026, 4:00 PM EDT
0.3890
+0.0030 (0.78%)
After-hours: Mar 13, 2026, 7:49 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $61.42 million as of March 13, 2026. Its market cap has decreased by -83.81% in one year.
Market Cap
61.42M
Enterprise Value
13.12M
1-Year Change
-83.81%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $61.42M, a decrease of -50.79%. That is a compound annual growth rate of -9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 61.42M | -7.37% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 65.62M |
| TScan Therapeutics | 65.44M |
| InflaRx | 65.17M |
| LeonaBio | 64.51M |
| ImageneBio | 64.01M |
| Entera Bio | 63.74M |
| eXoZymes | 62.67M |
| Alterity Therapeutics | 62.23M |